RealTime eClinical Solutions has rolled out the TrialAlign platform that aims to refine the processes of choosing sites, feasibility assessment, and performance analytics for clinical studies.
The platform’s introduction marks a shift in how stakeholders assess site feasibility and monitor trial performance by offering them access to real-time data.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
It will assist sponsors and contract research organisations (CROs) in making decisions on trial placement.
A key feature of TrialAlign is its reliance on unbiased data sourced from the RealTime-Devana platform, which captures insights from various research sites that are performing well globally.
This allows sponsors to digitally transmit feasibility questions and study documents to sites and leads to reduced cycle times and improved study performance.
RealTime-Devana president and co-founder Barry Lake said: “Sponsors and CROs finally have access to the right data at the right time – patient screening and enrolment trends, feasibility turnaround times, contract execution speeds, and more.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalData“TrialAlign allows them to align the right sites with the right studies for better trial outcomes, with the best outcome being faster delivery of novel therapies to patients in need.”
Additionally, the platform provides immediate access to critical performance indicators such as institutional review board (IRB) submission times and subject enrolment rates, which help sponsors determine the ideal sites for study initiation.
It also aids in detecting sites that have the necessary expertise and performance history for specific medical indications.
The platform enables accurate capture of trial data, decreases trial expenses, and accelerates the process of bringing new treatments to patients.
The company’s eClinical platform is developed for a wide array of clinical research stakeholders, including site networks, research sites, academic medical centres, CROs, and sponsors.
